---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-099762"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T04:53:09.933547+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DarioHealth extends Series B-3 mandatory conversion period and increases dividends

## Summary
- Mandatory conversion period extended from 15 to 18 months from original issue date.
- Dividends increased: 10% for fifth full quarter and 25% for sixth quarter from closing.
- No additional securities were issued or sold as a result of the amendment.
- Amendment effective September 11, 2024, approved by majority of preferred stock holders.

## SEC filing metadata
- accession: 0001104659-24-099762
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465924099762/0001104659-24-099762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465924099762/tm2418444d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-099762
- JSON: https://secwatch.observer/filing/0001104659-24-099762.json
- Plain text: https://secwatch.observer/filing/0001104659-24-099762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.